The REACT-1 team from Imperial College London has now completed round 16 of their study looking at virus prevalence across … read more
The new report (Report 50: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-50-severity-omicron/) from the Imperial College London COVID-19 response team estimates hospitalisation risk for Omicron cases … read more
The EAVE II (Early Pandemic Evaluation and Enhanced Surveillance of COVID-19) project has been tracking the COVID-19 pandemic in near … read more
Imperial modelling has come out which looks at: Imperial Report 49: Growth, population distribution and immune escape of Omicron in … read more
A national study called The Platform Adaptive trial of NOvel antiviRals for eArly treatMent of covid-19 In the Community (PANORAMIC), … read more
Launched in summer 2020, the PHOSP-COVID study aims to understand and improve long-term health outcomes for patients who have been … read more
Scientists undertook a self-controlled case series to investigate the risk of developing of myocarditis, pericarditis, and cardiac arrhythmias within 28 … read more
Scientists running the COM-COV study have done some preliminary analysis of neutralising antibody titres against the omicron variant, from samples … read more
Modellers at the London School of Hygiene and Tropical Medicine have produced some modelling looking at omicron and potential transmission … read more
Clinical trials can deliver pioneering new treatments for cancer patients – so why are so many people missing out on … read more
In June we heard from the team running the COM-COV trial giving results of mixed vaccine schedules on the immune … read more
New research, from a team from Imperial College London and Queen Mary University of London and published in Science, looks … read more
The House of Lords opened an inquiry into Risk Assessment and Planning in October 2020. They have assessed UK government planning … read more
This final quarterly report from Dr Raghib Ali, the government’s independent adviser on COVID-19 and ethnicity, brings together, for the … read more
COV-BOOST is a blinded, multicentre, randomised, controlled, phase 2 trial investigating safety and immunogenicity of seven COVID-19 vaccines as a … read more
The use of genome editing technologies in the breeding of farmed animals could potentially offer some new ways to help … read more
The EAVE II (Early Pandemic Evaluation and Enhanced Surveillance of COVID-19) project has been tracking the COVID-19 pandemic in near … read more
We asked some variant experts to make themselves available today to answer journalist questions at a Q&A about what we … read more
Seqirus, a leading manufacturer that specialises in flu vaccines, put together a panel of their experts who were available to … read more
We recently heard from the REACT-1 scientists with interim results from round 15 of their study looking at virus prevalence … read more
